Is The Bad News Priced Into Nike Stock Now?
Despite its dominance in the athletic shoe and apparel industry,…
Sell
42
WEN Quote, Financials, Valuation and Earnings
Last price:
$14.08
Seasonality move
:
1.22%
Day range:
$14.60 - $14.87
52-week range:
$13.72 - $20.65
Dividend yield:
6.83%
P/E ratio:
15.42x
P/S ratio:
1.34x
P/B ratio:
11.32x
Volume:
4.7M
Avg. volume:
5.3M
1-year change:
-20.85%
Market cap:
$2.9B
Revenue:
$2.2B
EPS (TTM):
$0.95
Analysts' Opinion
-
Consensus RatingThe Wendy's has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 20 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $17.47, The Wendy's has an estimated upside of 19.23% from its current price of $14.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $14.65.
Fair Value
-
According to the consensus of 25 analysts, The Wendy's has 19.23% upside to fair value with a price target of $17.47 per share.
WEN vs. S&P 500
-
Over the past 5 trading days, The Wendy's has underperformed the S&P 500 by -2.19% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Wendy's does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Wendy's has grown year-over-year revenues for 12 quarters straight. In the most recent quarter The Wendy's reported revenues of $574.3M.
Earnings Growth
-
The Wendy's has grown year-over-year earnings for 0 quarters straight. In the most recent quarter The Wendy's reported earnings per share of $0.23.
Enterprise value:
5.2B
EV / Invested capital:
--
Price / LTM sales:
1.34x
EV / EBIT:
13.19x
EV / Revenue:
2.33x
PEG ratio (5yr expected):
14.60x
EV / Free cash flow:
20.03x
Price / Operating cash flow:
11.54x
Enterprise value / EBITDA:
9.43x
Gross Profit (TTM):
$797.1M
Return On Assets:
3.8%
Net Income Margin (TTM):
8.65%
Return On Equity:
69.59%
Return On Invested Capital:
6.41%
Operating Margin:
19.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.1B | $2.2B | $2.2B | $540.7M | $574.3M | |
| Gross Profit | $689.9M | $783.9M | $797.1M | $305M | $325.2M | |
| Operating Income | $349.9M | $391.6M | $389M | $95.4M | $113.2M | |
| EBITDA | $501.6M | $552M | $554.2M | $137.2M | $138.9M | |
| Diluted EPS | $0.82 | $0.98 | $0.95 | $0.23 | $0.23 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $687.6M | $592.8M | $1.1B | $837.7M | $736.1M | |
| Total Assets | $5B | $5.1B | $5.5B | $5.2B | $5B | |
| Current Liabilities | $413.3M | $426.9M | $388M | $381.9M | $397.6M | |
| Total Liabilities | $4.5B | $4.7B | $5B | $4.9B | $4.8B | |
| Total Equity | $549.6M | $436.4M | $465.7M | $309.8M | $259.4M | |
| Total Debt | $2.2B | $2.4B | $2.9B | $2.8B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $259.9M | $345.4M | $355.3M | $75.9M | $68.6M | |
| Cash From Investing | -$77.8M | -$86.5M | -$129.3M | -$31M | -$60.5M | |
| Cash From Financing | $288.7M | -$504.3M | -$303.1M | -$131.1M | -$52.5M | |
| Free Cash Flow | $174.4M | $260.4M | $260.9M | $46.6M | $26.6M | |
WEN
Sector
Market Cap
$2.9B
$417.1M
Price % of 52-Week High
70.94%
69.3%
Dividend Yield
6.83%
0%
Shareholder Yield
8.81%
3.88%
1-Year Price Total Return
-20.85%
-17.24%
Beta (5-Year)
0.611
0.834
Dividend yield:
6.83%
Annualized payout:
$1.00
Payout ratio:
105.19%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$14.75
200-day SMA
Sell
Level
$16.78
Bollinger Bands (100)
Sell
Level
14.56 - 17.72
Chaikin Money Flow
Sell
Level
-23.6M
20-day SMA
Sell
Level
$15.08
Relative Strength Index (RSI14)
Sell
Level
42.10
ADX Line
Sell
Level
15.4
Williams %R
Buy
Level
-81.982
50-day SMA
Sell
Level
$14.93
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
646.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3152)
Sell
CA Score
(Annual)
Level (-1.9831)
Buy
Beneish M-Score
(Annual)
Level (-2.7769)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.4265)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Wendy’s Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald’s ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby’s (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy’s generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.
Stock Forecast FAQ
In the current month, WEN has received 4 Buy ratings 20 Hold ratings, and 1 Sell ratings. The WEN average analyst price target in the past 3 months is $17.47.
-
Where Will The Wendy's Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Wendy's share price will rise to $17.47 per share over the next 12 months.
-
What Do Analysts Say About The Wendy's?
Analysts are divided on their view about The Wendy's share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Wendy's is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is The Wendy's's Price Target?
The price target for The Wendy's over the next 1-year time period is forecast to be $17.47 according to 25 Wall Street analysts, 4 of them rate the stock a Buy, 1 rates the stock a Sell, and 20 analysts rate the stock a Hold.
-
Is WEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Wendy's is a Hold. 20 of 25 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of WEN?
You can purchase shares of The Wendy's via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Wendy's shares.
-
What Is The The Wendy's Share Price Today?
The Wendy's was last trading at $14.08 per share. This represents the most recent stock quote for The Wendy's. Yesterday, The Wendy's closed at $14.65 per share.
-
How To Buy The Wendy's Stock Online?
In order to purchase The Wendy's stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 10.04% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 7.68% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 7.29% over the past day.
